Vagus Nerve Stimulators (VNS) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

Vagus Nerve Stimulators (VNS) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update


Summary

GlobalData's Medical Devices sector report, “Vagus Nerve Stimulators (VNS) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Vagus Nerve Stimulators (VNS) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

A Vagus Nerve Stimulator is a device comprised of an electrical pacemaker that sends electrical stimulation through surgically implanted electrodes to target the vagus nerve. VNSs are utilized to treat neurological disorders such as epilepsy and depression.

Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Vagus Nerve Stimulators (VNS) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Vagus Nerve Stimulators (VNS) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Vagus Nerve Stimulators (VNS) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


  • Introduction
    • Vagus Nerve Stimulators (VNS) Overview
  • Products under Development
    • Vagus Nerve Stimulators (VNS) - Pipeline Products by Stage of Development
      • Table Vagus Nerve Stimulators (VNS) - Pipeline Products by Stage of Development
      • Table Vagus Nerve Stimulators (VNS) - Pipeline Products by Stage of Development
    • Vagus Nerve Stimulators (VNS) - Pipeline Products by Segment
      • Table Vagus Nerve Stimulators (VNS) - Pipeline Products by Segment
      • Table Vagus Nerve Stimulators (VNS) - Pipeline Products by Segment
    • Vagus Nerve Stimulators (VNS) - Pipeline Products by Territory
      • Table Vagus Nerve Stimulators (VNS) - Pipeline Products by Territory
      • Table Vagus Nerve Stimulators (VNS) - Pipeline Products by Territory
    • Vagus Nerve Stimulators (VNS) - Pipeline Products by Regulatory Path
      • Table Vagus Nerve Stimulators (VNS) - Pipeline Products by Regulatory Path
      • Table Vagus Nerve Stimulators (VNS) - Pipeline Products by Regulatory Path
    • Vagus Nerve Stimulators (VNS) - Pipeline Products by Estimated Approval Date
      • Table Vagus Nerve Stimulators (VNS) - Pipeline Products by Estimated Approval Date
      • Table Vagus Nerve Stimulators (VNS) - Pipeline Products by Estimated Approval Date
    • Vagus Nerve Stimulators (VNS) - Ongoing Clinical Trials
      • Table Vagus Nerve Stimulators (VNS) - Ongoing Clinical Trials
      • Table Vagus Nerve Stimulators (VNS) - Ongoing Clinical Trials
  • Vagus Nerve Stimulators (VNS) - Pipeline Products under Development by Companies
    • Vagus Nerve Stimulators (VNS) Companies - Pipeline Products by Stage of Development
      • Table Vagus Nerve Stimulators (VNS) Companies - Pipeline Products by Stage of Development
    • Vagus Nerve Stimulators (VNS) - Pipeline Products by Stage of Development
      • Table Vagus Nerve Stimulators (VNS) - Pipeline Products by Stage of Development
  • Vagus Nerve Stimulators (VNS) Companies and Product Overview
    • Adriakaim Inc Company Overview
      • Adriakaim Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Adriakaim Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vagus Nerve Stimulation Device - Product Status
        • Table Vagus Nerve Stimulation Device - Product Description
    • Bionics Institute Company Overview
      • Bionics Institute Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bionics Institute Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vagus Nerve Stimulation Device - Rheumatoid Arthritis - Product Status
        • Table Vagus Nerve Stimulation Device - Rheumatoid Arthritis - Product Description
    • Boston Scientific Corp Company Overview
      • Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vagus Nerve Stimulation (VNS) System - Product Status
        • Table Vagus Nerve Stimulation (VNS) System - Product Description
    • DuoCure Ltd. Company Overview
      • DuoCure Ltd. Pipeline Products & Ongoing Clinical Trials Overview
        • Table DuoCure Ltd. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Intraluminal Implantable Device - Product Status
        • Table Intraluminal Implantable Device - Product Description
    • ElectroCore Inc Company Overview
      • ElectroCore Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ElectroCore Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table GammaCore - Post-Traumatic Headache - Product Status
        • Table GammaCore - Post-Traumatic Headache - Product Description
        • Table Resolve Stimulator And Proximity Electrode - Product Status
        • Table Resolve Stimulator And Proximity Electrode - Product Description
    • LivaNova PLC Company Overview
      • LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Aspire NP - Product Status
        • Table Aspire NP - Product Description
        • Table Centro Generator - Product Status
        • Table Centro Generator - Product Description
        • Table CentroSR Generator - Product Status
        • Table CentroSR Generator - Product Description
        • Table Equilia - Product Status
        • Table Equilia - Product Description
        • Table Griffin - Pulse Generator - Product Status
        • Table Griffin - Pulse Generator - Product Description
        • Table Intense Neuromodulation System - Heart Failure - Product Status
        • Table Intense Neuromodulation System - Heart Failure - Product Description
        • Table Microburst VNS Stimulator - Product Status
        • Table Microburst VNS Stimulator - Product Description
        • Table PhoenixRF SR - Product Status
        • Table PhoenixRF SR - Product Description
    • LivaNova USA Inc Company Overview
      • LivaNova USA Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table LivaNova USA Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nerve Wrap - Product Status
        • Table Nerve Wrap - Product Description
    • MicroTransponder Inc Company Overview
      • MicroTransponder Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table MicroTransponder Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table SAINT System - Tinnitus - Product Status
        • Table SAINT System - Tinnitus - Product Description
        • Table Serenity System - Product Status
        • Table Serenity System - Product Description
        • Table Vivistim Paired VNS System - Product Status
        • Table Vivistim Paired VNS System - Product Description
        • Table MicroTransponder Inc - Ongoing Clinical Trials Overview
        • Table Vivistim Paired VNS System - Safety and Feasibility of Paired Vagus Nerve Stimulation With Rehabilitation for Improving Upper Extremity Function in People With Cervical Spinal Cord Injury: A Pilot Randomized Control Trial.
        • Table Vivistim Paired VNS System - Vagal Nerve Stimulation in Enhanced Stroke Recovery: The VALOR Registry
        • Table Vivistim Paired VNS System - Vagus Nerve Stimulation (VNS) During Rehabilitation Using the Vivistim System: Post-Market Study for Stroke Rehabilitation in a Home Environment for Subjects With Chronic Stroke (VNS-REHAB At-Home)
        • Table Vivistim Paired VNS System - Vivistim Registry for Paired VNS Therapy (GRASP)
    • Neurive Inc Company Overview
      • Neurive Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Neurive Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Healaon - Product Status
        • Table Healaon - Product Description
    • Neuroloop Gmbh Company Overview
      • Neuroloop Gmbh Pipeline Products & Ongoing Clinical Trials Overview
        • Table Neuroloop Gmbh Pipeline Products & Ongoing Clinical Trials Overview
        • Table Baroloop System - Product Status
        • Table Baroloop System - Product Description
        • Table Neurostimulation System - Product Status
        • Table Neurostimulation System - Product Description
        • Table Neuroloop Gmbh - Ongoing Clinical Trials Overview
        • Table Baroloop System - Baroloop Multicenter Trial (Baroloop MCT)
    • Nexeon MedSystems Inc Company Overview
      • Nexeon MedSystems Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nexeon MedSystems Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Auricular Vagus Nerve Stimulator - Asthma - Product Status
        • Table Auricular Vagus Nerve Stimulator - Asthma - Product Description
    • Otto Bock HealthCare GmbH Company Overview
      • Otto Bock HealthCare GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table Otto Bock HealthCare GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table Neuromodulation Device - Sleep Apnea - Product Status
        • Table Neuromodulation Device - Sleep Apnea - Product Description
    • Purdue University Company Overview
      • Purdue University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Purdue University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bionode Device - Product Status
        • Table Bionode Device - Product Description
    • ReShape Lifesciences Inc Company Overview
      • ReShape Lifesciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ReShape Lifesciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diabetes Bloc-Stim Neuromodulation Device - Product Status
        • Table Diabetes Bloc-Stim Neuromodulation Device - Product Description
        • Table Diabetes Bloc-Stim Neuromodulation Device - Hypoglycemia - Product Status
        • Table Diabetes Bloc-Stim Neuromodulation Device - Hypoglycemia - Product Description
    • Setpoint Medical Corp Company Overview
      • Setpoint Medical Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Setpoint Medical Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Implantable Bioelectronic Device - Product Status
        • Table Implantable Bioelectronic Device - Product Description
        • Table Setpoint Medical Corp - Ongoing Clinical Trials Overview
        • Table Implantable Bioelectronic Device - Vagus Nerve Stimulation Using the SetPoint System for Moderate to Severe Rheumatoid Arthritis: The RESET-RA Study
    • Synergia Medical SA Company Overview
      • Synergia Medical SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Synergia Medical SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table NAO·VNS - Chronic Pain - Product Status
        • Table NAO·VNS - Chronic Pain - Product Description
        • Table NAO·VNS - Depression - Product Status
        • Table NAO·VNS - Depression - Product Description
        • Table NAO·VNS - Epilepsy - Product Status
        • Table NAO·VNS - Epilepsy - Product Description
        • Table NAO·VNS - Parkinson's Disease - Product Status
        • Table NAO·VNS - Parkinson's Disease - Product Description
        • Table NAO·VNS - Sleep Apnoea - Product Status
        • Table NAO·VNS - Sleep Apnoea - Product Description
        • Table Synergia Medical SA - Ongoing Clinical Trials Overview
        • Table NAO·VNS - Epilepsy - A First in Human Study for Resistant Epilepsy With the Vagus Nerve Stimulation Device by Synergia Medical
    • The Feinstein Institute for Medical Research Company Overview
      • The Feinstein Institute for Medical Research Pipeline Products & Ongoing Clinical Trials Overview
        • Table The Feinstein Institute for Medical Research Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bioelectronic Medicine Device - Heart Failure - Product Status
        • Table Bioelectronic Medicine Device - Heart Failure - Product Description
        • Table Bioelectronic Medicine Device - Obesity - Product Status
        • Table Bioelectronic Medicine Device - Obesity - Product Description
    • Trifectas Medical Corp. Company Overview
      • Trifectas Medical Corp. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Trifectas Medical Corp. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Neurostimulation Device - Stroke Recovery - Product Status
        • Table Neurostimulation Device - Stroke Recovery - Product Description
    • tVNS Technologies GmbH Company Overview
      • tVNS Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table tVNS Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table t-VNS - Dementia - Product Status
        • Table t-VNS - Dementia - Product Description
    • University of Alabama Company Overview
      • University of Alabama Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Alabama Pipeline Products & Ongoing Clinical Trials Overview
        • Table VNS Device - Depression - Product Status
        • Table VNS Device - Depression - Product Description
    • University of Auckland Company Overview
      • University of Auckland Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Auckland Pipeline Products & Ongoing Clinical Trials Overview
        • Table Electroceutical Device - Product Status
        • Table Electroceutical Device - Product Description
    • University of Pittsburgh Company Overview
      • University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview
        • Table Closed-Loop Neuroelectric Device - Product Status
        • Table Closed-Loop Neuroelectric Device - Product Description
    • University of Wisconsin Madison Company Overview
      • University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview
        • Table Implantable Weight-Loss Device - Product Status
        • Table Implantable Weight-Loss Device - Product Description
    • West Virginia University Company Overview
      • West Virginia University Pipeline Products & Ongoing Clinical Trials Overview
        • Table West Virginia University Pipeline Products & Ongoing Clinical Trials Overview
        • Table MouseFlex - Product Status
        • Table MouseFlex - Product Description
  • Vagus Nerve Stimulators (VNS)- Recent Developments
    • Jul 10, 2024: Setpoint Medical Announces Positive Topline Results from Landmark Reset-Ra Study Evaluating Neuroimmune Modulation for the Treatment of Rheumatoid Arthritis
    • Jul 10, 2024: SetPoint Medical Announces Positive Topline Results from Landmark RESET-RA Study Evaluating Neuroimmune Modulation for the Treatment of Rheumatoid Arthritis
    • Jun 06, 2024: LivaNova Provides Update on RECOVER Clinical Study Evaluating VNS Therapy for Treatment-Resistant Depression in Unipolar Patients
    • Mar 21, 2024: SetPoint Medical Accepted into FDA Total Product Life Cycle Advisory Program for Development of its Neuroimmune Modulation Platform for the Treatment of Multiple Sclerosis
    • Mar 19, 2024: Tampa General Conducts First Procedure on the West Coast of Florida With Device Designed to Revive Arm Function After Stroke
    • Mar 13, 2024: SetPoint wins second FDA breakthrough device nod for neurostim device
    • Mar 13, 2024: SetPoint Medical Receives FDA Breakthrough Device Designation for its Neuroimmune Modulation Platform for the Treatment of Multiple Sclerosis
    • Mar 04, 2024: LivaNova to Present at the Barclays Global Healthcare Conference
    • Feb 28, 2024: Boston Scientific Raises $2.2B to Support Purchase of California Medical Device Company
    • Feb 23, 2024: Medical Tech Leader, Boston Scientific (BSX), Announces Notes Offering
    • Feb 23, 2024: Breakthrough Stroke Treatment at Penn State Health Offers Patients New Hope
    • Jan 05, 2024: Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 Results
    • Dec 26, 2023: electroCore Expands Intellectual Property Portfolio
    • Nov 15, 2023: Dr. Peter Staats to Host Analyst Day on the Science Behind gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) on Tuesday, November 21, 2023
    • Oct 24, 2023: TIME Picks MicroTransponder's Vivistim Paired VNS System for 2023 Best Inventions List in Medical Care Category
    • Oct 17, 2023: electroCore Announces Two-Year Extension of gammaCore Device Listing in the NHS Supply Chain Catalogue
    • Oct 11, 2023: electroCore Expands Intellectual Property Portfolio for Non-Invasive Vagus Nerve Stimulation (nVNS) Technology
    • Oct 03, 2023: SetPoint Medical Announces Publication of Data for Neuroimmune Modulation to Treat Crohn's Disease in Journal of Crohn's and Colitis
    • Sep 14, 2023: ReShape Lifesciences Receives NIH SBIR Grant to Further Develop Proprietary Diabetes Bloc-Stim Neuromodulation Device
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings